Ansell shares (ASX: ANN) crashed through key support levels to fresh 52-week lows at A$27.07, capping a brutal week that saw the healthcare and industrial protection specialist shed 9% amid surging volumes and mounting technical concerns.

The Ansell share price heads into the new week at A$27.13, down 22.93% year-to-date, with more than one million shares changing hands on each of the final two trading days of last week, more than double the average daily volume, as selling intensified into the weekend. The Relative Strength Index has fallen to 31.25, approaching oversold territory but offering little comfort to shareholders who have watched the company shed nearly a quarter of its value in less than four months despite what appeared to be solid fundamentals in the last print.

The latest selloff marks a decisive break below multiple technical support levels that had held since late 2023. On 30 January 2026, Ansell breached a long-term upward trendline dating back to October 2023, and on 9 March, the stock broke the neckline of a significant head-and-shoulders pattern that had been forming since April 2025. These classic bearish reversal signals have now been confirmed by the sustained selling pressure, with shares dropping over 7% from an early-April pivot high around A$28.77.

Fundamentals Look Better Than Technicals

The technical deterioration comes despite fundamentally sound recent results. Ansell reported profit before net financing and tax of approximately $139.6 million for the first half of fiscal 2026, up substantially from $97.1 million in the prior corresponding period. The company has also been actively executing an on-market share buyback program, recently canceling over one million shares acquired on-market as part of what management frames as an effort to return capital and optimize the balance sheet.

The buyback, which in normal market conditions would provide a floor under the share price, has proven insufficient to stem the tide of institutional selling. The fact that shares continue to make new lows despite active share cancellations, which mechanically boost earnings per share, suggests markets are pricing in deeper concerns about the sustainability of recent earnings growth or the trajectory of the company’s end markets.

 

Top Australian Brokers

Ansell operates at the intersection of healthcare, industrial, and personal protective equipment demand, a sector still working through post-pandemic normalization. While the integration of the Kimberly-Clark healthcare gloves business acquired in 2024 has progressed ahead of schedule and contributed to the improved first-half results, technical analysts have noted that the company faces significant operational headwinds that have tempered sentiment despite its robust financial foundation.

The valuation picture adds complexity to the debate. Ansell currently trades at a price-to-earnings ratio around 24 times, approximately 40 to 50 percent above some sector medians. In a risk-off environment where markets are rotating away from cyclically exposed names, above-median multiples become vulnerable to compression, particularly when questions arise about whether recent strong earnings represent a sustainable run-rate or a cyclical peak.

What Next For Ansell?

The heavy volume accompanying the breakdown to new lows is typically interpreted as institutional distribution or capitulation, confirming the new lower trading range rather than signalling exhaustion. While the approaching oversold reading on the RSI could precede a reflexive bounce, particularly with buyback support still in place, prices can remain oversold for extended periods during strong downtrends.

The coming weeks will be critical in determining whether the current levels represent genuine value or a waypoint in a longer period of selling pressure. Markets will be watching for any updates to fiscal 2026 guidance, with the August update a key one. For now, pressure is on following lows being made on heavy volume, and bulls will be looking for some support to step in to steady the ship.

Bull Case:

  • First-half fiscal 2026 profit up 44% year-on-year to $139.6 million
  • Active share buyback mechanically supports earnings per share and signals management confidence
  • RSI near 31 suggests oversold conditions may precede tactical bounce
  • Kimberly-Clark acquisition integration progressing ahead of schedule with visible synergies
  • Balance sheet and cash flow profile remain solid, limiting downside risk

Bear Case:

  • Confirmed head-and-shoulders breakdown suggests multi-month downtrend still unfolding from here
  • Trading at 24x P/E, roughly 40-50% above sector median valuation
  • Significant operational headwinds may mean recent earnings represent cyclical peak not baseline
  • Heavy institutional selling on 2x average volume signals continued distribution pressure ahead
  • Post-COVID PPE normalization creates margin and volume growth headwinds through 2026
The Bull Team
The Bull Team is a group of finance writers and journalists that provide commentary and insights on the Australian stock market and beyond.